Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin*1
- 1 October 2004
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 113 (1) , 38-46
- https://doi.org/10.1016/j.clim.2004.06.001
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: